webinar register page

Webinar banner
Applying Microbiome Science in Clinical Practice: stool testing, novel strains, and protocol development
"Clostridium butyricum and Akkermansia muciniphila are 2 novel strains that every practitioner should know about."

Join Dr. Kara Fitzgerald and Colleen Cutcliffe, the founder and CEO of Pendulum Therapeutics, for a discussion on exciting novel strains and their impact on the microbiome, application of stool testing and microbiome-targeted protocols that can shape the future of health and more.

In this webinar learn about:
- Mechanisms of action and synergistic effects of Clostridium butyricum and Akkermansia muciniphila
- Common conditions that may benefit from these novel strains
- How to interpret stool test results & build protocols
- The role of polyphenols and much more!

This content is available live during the event and afterwards as a video recording, for a limited time, to registered attendees only. If you can’t attend live (or aren’t sure if you can), register to ensure you receive the recording notification and access.

Feb 2, 2023 04:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Kara Fitzgerald.